Skip to main content
Journal cover image

Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.

Publication ,  Journal Article
Beermann, KJ; Ellis, MJ; Sudan, DL; Harris, MT
Published in: Clin Transplant
July 2014

Racial differences among kidney transplant recipients may impact the total daily tacrolimus dose required to achieve therapeutic tacrolimus concentrations. Previous studies suggest that African Americans require higher doses to achieve similar therapeutic drug concentrations compared with Caucasians. Data were collected on a total of 147 de novo kidney transplant recipients. Tacrolimus total daily dose (TDD) requirements (mg/kg/d) and tacrolimus concentrations were retrospectively reviewed at discharge and at days 30, 60, and 90 after transplant. TDD requirements in African-American and Caucasian patients were 0.14 mg/kg/d and 0.11 mg/kg/d, respectively (p = 0.005), at day 30. TDD requirements at day of hospital discharge and days 60 and 90 following transplant were significantly higher in African-American patients vs. Caucasian patients, with similar tacrolimus concentrations at all time points. This study suggests that when compared to Caucasians, African Americans require significantly higher TDD of tacrolimus to achieve similar tacrolimus concentrations. These findings provide transplant clinicians with a sense of certainty to more rapidly titrate daily tacrolimus doses in African-American patients to achieve therapeutic concentrations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Transplant

DOI

EISSN

1399-0012

Publication Date

July 2014

Volume

28

Issue

7

Start / End Page

762 / 767

Location

Denmark

Related Subject Headings

  • White People
  • Transplant Recipients
  • Tacrolimus
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Prednisone
  • Postoperative Complications
  • Mycophenolic Acid
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Beermann, K. J., Ellis, M. J., Sudan, D. L., & Harris, M. T. (2014). Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. Clin Transplant, 28(7), 762–767. https://doi.org/10.1111/ctr.12376
Beermann, Kristi J., Matthew J. Ellis, Debra L. Sudan, and Matthew T. Harris. “Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.Clin Transplant 28, no. 7 (July 2014): 762–67. https://doi.org/10.1111/ctr.12376.
Beermann KJ, Ellis MJ, Sudan DL, Harris MT. Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. Clin Transplant. 2014 Jul;28(7):762–7.
Beermann, Kristi J., et al. “Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.Clin Transplant, vol. 28, no. 7, July 2014, pp. 762–67. Pubmed, doi:10.1111/ctr.12376.
Beermann KJ, Ellis MJ, Sudan DL, Harris MT. Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. Clin Transplant. 2014 Jul;28(7):762–767.
Journal cover image

Published In

Clin Transplant

DOI

EISSN

1399-0012

Publication Date

July 2014

Volume

28

Issue

7

Start / End Page

762 / 767

Location

Denmark

Related Subject Headings

  • White People
  • Transplant Recipients
  • Tacrolimus
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Prednisone
  • Postoperative Complications
  • Mycophenolic Acid